Target intelligence / Profile preview

Ankyrin repeat and FYVE domain containing 1 (ANKFY1)

Target
ANKFY1
Molecular classification
Double zinc finger protein, Rab5 effector, Vesicle/protein trafficking factor, Cytoplasmic protein
01

Overview

Ankyrin repeat and FYVE domain containing 1 (ANKFY1) is a cytoplasmic protein characterized by a coiled-coil structure, a BTB/POZ domain at the N-terminus, multiple ankyrin repeats, and a FYVE-finger domain at the C-terminus[1][3][5]. As a Rab5 effector binding phosphatidylinositol 3-phosphate (PI(3)P) through its FYVE domain, ANKFY1 localizes to early endosomes and is essential for their formation and function[4]. It regulates intracellular trafficking and receptor trafficking, as demonstrated in endothelial cells where its depletion reduces surface expression of VEGF receptor 2, impairing downstream signaling important for cell proliferation and migration[1]. In neurons, particularly cerebellar Purkinje cells, ANKFY1 is necessary for cell maintenance, and its loss in mice leads to Purkinje cell degeneration and motor dysfunction, suggesting involvement in neurodegenerative processes[2]. Alternative splicing generates multiple transcript variants. Currently, ANKFY1 is not recognized as a direct drug target or therapeutic receptor, but its roles in cell trafficking and neurodegeneration continue to be areas of study[1][2][5].

Other names
ZFYVE14ANKHZNBTBD23ankyrin repeat and FYVE domain containing 1
02

Biological functions

Intracellular vesicle and protein transportRegulation of receptor traffickingMembrane traffickingEndosomal formation and maintenanceMaintenance of neuronal cells (notably Purkinje cells)Regulation of growth factor signaling (e.g., VEGFR2, PDGF pathways)
03

Disease associations

Neurodegenerative disease (e.g., spastic ataxia, cerebellar ataxia, Purkinje cell degeneration)Possibly implicated in certain cancers through receptor traffickingCoenzyme Q10 deficiency diseaseHereditary steroid-resistant nephrotic syndrome

Beyond the preview

Go deeper on Ankyrin repeat and FYVE domain containing 1 (ANKFY1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat and FYVE domain containing 1 (ANKFY1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call